Found: 79
Select item for more details and to access through your institution.
Clinical characteristics and outcomes of patients with chronic disseminated candidiasis who need adjuvant corticosteroid therapy.
- Published in:
- Medical Mycology, 2018, v. 56, n. 6, p. 782, doi. 10.1093/mmy/myx110
- By:
- Publication type:
- Article
The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 9, p. 2427, doi. 10.1007/s00432-021-03781-6
- By:
- Publication type:
- Article
Prediction of epithelial-to-mesenchymal transition molecular subtype using CT in gastric cancer.
- Published in:
- European Radiology, 2022, v. 32, n. 1, p. 1, doi. 10.1007/s00330-021-08094-3
- By:
- Publication type:
- Article
Increased risk of pancreatic cancer in individuals with non-alcoholic fatty liver disease.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-14856-w
- By:
- Publication type:
- Article
Detection of Fusion Genes Using a Targeted RNA Sequencing Panel in Gastrointestinal and Rare Cancers.
- Published in:
- Journal of Oncology, 2020, p. 1, doi. 10.1155/2020/4659062
- By:
- Publication type:
- Article
ATM Expression as a Prognostic Marker in Patients With Advanced Biliary Tract Cancer Treated With First-line Gemcitabine and Platinum Chemotherapy.
- Published in:
- In Vivo, 2021, v. 35, n. 1, p. 499, doi. 10.21873/invivo.12284
- By:
- Publication type:
- Article
Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial.
- Published in:
- Genome Medicine, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13073-021-00995-8
- By:
- Publication type:
- Article
Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial.
- Published in:
- Genome Medicine, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13073-021-00826-w
- By:
- Publication type:
- Article
The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221113266
- By:
- Publication type:
- Article
Determining Which Patients Require Preoperative Pelvic Radiotherapy Before Curative-Intent Surgery and/or Ablation for Metastatic Rectal Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 7, p. 4197, doi. 10.1245/s10434-022-11592-3
- By:
- Publication type:
- Article
ASO Visual Abstract: Determining Which Patients Require Preoperative Pelvic Radiotherapy Before Curative Intent Surgery and/or Ablation for Metastatic Rectal Cancer.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Regional Lymph Node Metastasis of Scalp Angiosarcoma: A Detailed Clinical Observation Study of 40 Cases.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 8, p. 3018, doi. 10.1245/s10434-020-08408-7
- By:
- Publication type:
- Article
Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 5, p. 877, doi. 10.1007/s10637-018-0582-0
- By:
- Publication type:
- Article
Favorable clinical efficacy of cytotoxic chemotherapy in patients with progressive desmoid tumors: a retrospective real-world study.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 853, doi. 10.1007/s10147-024-02506-2
- By:
- Publication type:
- Article
How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 2, p. 636, doi. 10.4143/crt.2022.343
- By:
- Publication type:
- Article
Comprehensive Molecular Characterization of Soft Tissue Sarcoma for Prediction of Pazopanib-Based Treatment Response.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 2, p. 671, doi. 10.4143/crt.2022.251
- By:
- Publication type:
- Article
Genomic Sequencing for Bladder Urothelial Carcinoma and Its Clinical Implications for Immunotherapy.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 3, p. 894, doi. 10.4143/crt.2021.854
- By:
- Publication type:
- Article
Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30--Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 2, p. 374, doi. 10.4143/crt.2019.198
- By:
- Publication type:
- Article
Comprehensive molecular profiling to predict clinical outcomes in pancreatic cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211038478
- By:
- Publication type:
- Article
Clinical sequencing to assess tumor mutational burden as a useful biomarker to immunotherapy in various solid tumors.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921992992
- By:
- Publication type:
- Article
Clinical sequencing to assess tumor mutational burden as a useful biomarker to immunotherapy in various solid tumors.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921992992
- By:
- Publication type:
- Article
Comprehensive molecular profiling to predict clinical outcomes in pancreatic cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211038478
- By:
- Publication type:
- Article
Clinical and molecular distinctions in patients with refractory colon cancer who benefit from regorafenib treatment.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920965842
- By:
- Publication type:
- Article
First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patients.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920926796
- By:
- Publication type:
- Article
Genetic Aberrations in Imatinib-Resistant Dermatofibrosarcoma Protuberans Revealed by Whole Genome Sequencing.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0069752
- By:
- Publication type:
- Article
A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Thiotepa, busulfan, and cyclophosphamide or busulfan, cyclophosphamide, and etoposide high-dose chemotherapy followed by autologous stem cell transplantation for consolidation of primary central nervous system lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The cell-of-origin classification of diffuse large B cell lymphoma in a Korean population by the Lymph2Cx assay and its correlation with immunohistochemical algorithms.
- Published in:
- Annals of Hematology, 2018, v. 97, n. 12, p. 2363, doi. 10.1007/s00277-018-3442-2
- By:
- Publication type:
- Article
Treating synchronous bilateral ocular adnexal marginal zone lymphoma: the consortium for improving survival of lymphoma study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The cell-of-origin classification of diffuse large B cell lymphoma in a Korean population by the Lymph2Cx assay and its correlation with immunohistochemical algorithms.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Incorporating sarcopenia and inflammation with radiation therapy in patients with hepatocellular carcinoma treated with nivolumab.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 6, p. 1593, doi. 10.1007/s00262-020-02794-3
- By:
- Publication type:
- Article
Adverse Effect of the Duration of Antibiotic Use Prior to Immune Checkpoint Inhibitors on the Overall Survival of Patients with Recurrent Gynecologic Malignancies.
- Published in:
- Cancers, 2023, v. 15, n. 24, p. 5745, doi. 10.3390/cancers15245745
- By:
- Publication type:
- Article
A Machine Learning Approach Using FDG PET-Based Radiomics for Prediction of Tumor Mutational Burden and Prognosis in Stage IV Colorectal Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 15, p. 3841, doi. 10.3390/cancers15153841
- By:
- Publication type:
- Article
Impact of Radiotherapy on Kidney Function among Patients Who Received Adjuvant Treatment for Gastric Cancer: Logistic and Linear Regression Analyses.
- Published in:
- Cancers, 2021, v. 13, n. 1, p. 59, doi. 10.3390/cancers13010059
- By:
- Publication type:
- Article
Incidence of FGFR2 Amplification and FGFR2 Fusion in Patients with Metastatic Cancer Using Clinical Sequencing.
- Published in:
- Journal of Oncology, 2022, p. 1, doi. 10.1155/2022/9714570
- By:
- Publication type:
- Article
Efficacy and safety of atezolizumab plus bevacizumab in Korean patients with advanced hepatocellular carcinoma.
- Published in:
- Liver International, 2022, v. 42, n. 3, p. 674, doi. 10.1111/liv.15102
- By:
- Publication type:
- Article
Regorafenib in patients with advanced Child‐Pugh B hepatocellular carcinoma: A multicentre retrospective study.
- Published in:
- Liver International, 2020, v. 40, n. 10, p. 2544, doi. 10.1111/liv.14573
- By:
- Publication type:
- Article
Association between Smoking Cessation and the Risk of Cholangiocarcinoma and Ampulla of Vater Cancer: A Nationwide Cohort Study.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 5, p. 457, doi. 10.1159/000529609
- By:
- Publication type:
- Article
Treatment outcomes of advanced/metastatic extramammary Paget's disease in Korean patients: KCSG‐RC20‐06.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 14, p. 15159, doi. 10.1002/cam4.6190
- By:
- Publication type:
- Article
Comprehensive immunoprofile analysis of prognostic markers in pancreaticobiliary tract cancers.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 7, p. 7748, doi. 10.1002/cam4.5530
- By:
- Publication type:
- Article
Reducing tumor invasiveness by ramucirumab and TGF‐β receptor kinase inhibitor in a diffuse‐type gastric cancer patient‐derived cell model.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 20, p. 7253, doi. 10.1002/cam4.4259
- By:
- Publication type:
- Article
Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 197, doi. 10.3350/cmh.2022.0404
- By:
- Publication type:
- Article
Costing Rule and Cost Behavior in the Korean Defense Industry.
- Published in:
- Seoul Journal of Business, 2015, v. 21, n. 1, p. 31, doi. 10.35152/snusjb.2015.21.1.002
- By:
- Publication type:
- Article
MET gene alterations predict poor survival following chemotherapy in patients with advanced cancer.
- Published in:
- Pathology & Oncology Research, 2022, p. 01, doi. 10.3389/pore.2022.1610697
- By:
- Publication type:
- Article
Prognostic Impact of Sarcopenia and Radiotherapy in Patients With Advanced Gastric Cancer Treated With Anti-PD-1 Antibody.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.701668
- By:
- Publication type:
- Article
Managing Cytokine Release Syndrome and Neurotoxicity with Step-Up Dosing of Mosunetuzumab in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S247, doi. 10.1016/j.clml.2019.07.151
- By:
- Publication type:
- Article